Literature DB >> 31560048

Perils, Pitfalls, and Promise of Primary Prophylaxis for Clostridioides difficile Infection.

Kevin W Garey1.   

Abstract

Entities:  

Keywords:  anaerobe infections; clinical trials; healthcare-acquired infections; primary prevention; vancomycin

Year:  2020        PMID： 31560048      PMCID： PMC7442846          DOI： 10.1093/cid/ciz970

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  12 in total

1.  Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic Exposure.

Authors:  Steven W Johnson; Shannon V Brown; David H Priest
Journal:  Clin Infect Dis       Date:  2020-08-22       Impact factor: 9.079

2.  Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial.

Authors:  Dale N Gerding; Thomas Meyer; Christine Lee; Stuart H Cohen; Uma K Murthy; Andre Poirier; Trevor C Van Schooneveld; Darrell S Pardi; Antonio Ramos; Michelle A Barron; Hongzi Chen; Stephen Villano
Journal:  JAMA       Date:  2015-05-05       Impact factor: 56.272

3.  Host and pathogen factors for Clostridium difficile infection and colonization.

Authors:  Vivian G Loo; Anne-Marie Bourgault; Louise Poirier; François Lamothe; Sophie Michaud; Nathalie Turgeon; Baldwin Toye; Axelle Beaudoin; Eric H Frost; Rodica Gilca; Paul Brassard; Nandini Dendukuri; Claire Béliveau; Matthew Oughton; Ivan Brukner; Andre Dascal
Journal:  N Engl J Med       Date:  2011-11-03       Impact factor: 91.245

4.  Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.

Authors:  Stuart Johnson; Thomas J Louie; Dale N Gerding; Oliver A Cornely; Scott Chasan-Taber; David Fitts; Steven P Gelone; Colin Broom; David M Davidson
Journal:  Clin Infect Dis       Date:  2014-05-05       Impact factor: 9.079

5.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

Authors:  L Clifford McDonald; Dale N Gerding; Stuart Johnson; Johan S Bakken; Karen C Carroll; Susan E Coffin; Erik R Dubberke; Kevin W Garey; Carolyn V Gould; Ciaran Kelly; Vivian Loo; Julia Shaklee Sammons; Thomas J Sandora; Mark H Wilcox
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

6.  Increasing antibiotic resistance in Clostridioides difficile: A systematic review and meta-analysis.

Authors:  Srishti Saha; Saloni Kapoor; Raseen Tariq; Audrey N Schuetz; Pritish K Tosh; Darrell S Pardi; Sahil Khanna
Journal:  Anaerobe       Date:  2019-07-19       Impact factor: 3.331

7.  Burden of Clostridium difficile infection in the United States.

Authors:  Fernanda C Lessa; Yi Mu; Wendy M Bamberg; Zintars G Beldavs; Ghinwa K Dumyati; John R Dunn; Monica M Farley; Stacy M Holzbauer; James I Meek; Erin C Phipps; Lucy E Wilson; Lisa G Winston; Jessica A Cohen; Brandi M Limbago; Scott K Fridkin; Dale N Gerding; L Clifford McDonald
Journal:  N Engl J Med       Date:  2015-02-26       Impact factor: 91.245

8.  Multicentre derivation and validation of a simple predictive index for healthcare-associated Clostridium difficile infection.

Authors:  M L Davis; H G Sparrow; J O Ikwuagwu; W L Musick; K W Garey; K K Perez
Journal:  Clin Microbiol Infect       Date:  2018-02-16       Impact factor: 8.067

9.  Short- and long-term effects of oral vancomycin on the human intestinal microbiota.

Authors:  Sandrine Isaac; Jose U Scher; Ana Djukovic; Nuria Jiménez; Dan R Littman; Steven B Abramson; Eric G Pamer; Carles Ubeda
Journal:  J Antimicrob Chemother       Date:  2016-10-05       Impact factor: 5.790

10.  A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile-associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation.

Authors:  Kathleen M Mullane; Drew J Winston; Ajay Nooka; Michele I Morris; Patrick Stiff; Michael J Dugan; Henry Holland; Kevin Gregg; Javier A Adachi; Steven A Pergam; Barbara D Alexander; Erik R Dubberke; Natalya Broyde; Sherwood L Gorbach; Pamela S Sears
Journal:  Clin Infect Dis       Date:  2019-01-07       Impact factor: 9.079
View more
  1 in total

Review 1.  Oral Vancomycin Prophylaxis for Primary and Secondary Prevention of Clostridioides difficile Infection in Patients Treated with Systemic Antibiotic Therapy: A Systematic Review, Meta-Analysis and Trial Sequential Analysis.

Authors:  Alberto Enrico Maraolo; Maria Mazzitelli; Emanuela Zappulo; Riccardo Scotto; Guido Granata; Roberto Andini; Emanuele Durante-Mangoni; Nicola Petrosillo; Ivan Gentile
Journal:  Antibiotics (Basel)       Date:  2022-01-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.